Search Tag: Women's Health
2025 18 Feb
Invasive lobular carcinoma (ILC) is the second most common histologic subtype of breast cancer, accounting for 5% to 15% of all cases. Unlike invasive ductal carcinoma (IDC), ILC has an infiltrative growth pattern that makes detection challenging with traditional screening methods. Its lack of cell cohesion and tendency to grow in single-file...Read more
2025 18 Feb
Invasive lobular carcinoma (ILC) is the second most common histologic subtype of breast cancer, accounting for 5% to 15% of all cases. Unlike invasive ductal carcinoma (IDC), ILC has an infiltrative growth pattern that makes detection challenging with traditional screening methods. Its lack of cell cohesion and tendency to grow in single-file...Read more
2025 08 Feb
Breast cancer screening is a crucial tool in early detection, enabling timely intervention and improving survival rates. While women at high risk due to genetic mutations or previous chest irradiation are recommended for regular MRI screening alongside mammography, those with an intermediate risk often receive only mammography. This group, which...Read more
2025 08 Feb
Breast cancer screening is a crucial tool in early detection, enabling timely intervention and improving survival rates. While women at high risk due to genetic mutations or previous chest irradiation are recommended for regular MRI screening alongside mammography, those with an intermediate risk often receive only mammography. This group, which...Read more
2025 08 Feb
Breast cancer screening is a crucial tool in early detection, enabling timely intervention and improving survival rates. While women at high risk due to genetic mutations or previous chest irradiation are recommended for regular MRI screening alongside mammography, those with an intermediate risk often receive only mammography. This group, which...Read more
2024 07 Oct
Breast cancer remains one of the leading causes of cancer-related mortality among women. Accurate classification of breast cancer subtypes, based on molecular biomarkers such as oestrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), is critical for guiding treatment decisions and predicting outcomes....Read more
2024 07 Oct
Breast cancer remains one of the leading causes of cancer-related mortality among women. Accurate classification of breast cancer subtypes, based on molecular biomarkers such as oestrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), is critical for guiding treatment decisions and predicting outcomes....Read more
2024 02 Oct
Breast cancer is the most common cancer among women worldwide and remains a significant cause of cancer-related mortality. Traditional diagnostic approaches rely on biopsies and histopathological examinations to determine the prognosis and guide treatment. However, non-invasive imaging techniques, such as Ultrasound-Guided Diffuse Optical Tomography...Read more
2024 02 Oct
Breast cancer is the most common cancer among women worldwide and remains a significant cause of cancer-related mortality. Traditional diagnostic approaches rely on biopsies and histopathological examinations to determine the prognosis and guide treatment. However, non-invasive imaging techniques, such as Ultrasound-Guided Diffuse Optical Tomography...Read more
2024 25 Aug
Endometriosis, a chronic condition affecting over 1.5 million women and those assigned female at birth in the UK alone, remains underdiagnosed and underfunded despite its significant impact on lives. This disease, which can severely affect education, careers, relationships, fertility, and overall quality of life, is still unknown to many. With...Read more
2024 25 Aug
Endometriosis, a chronic condition affecting over 1.5 million women and those assigned female at birth in the UK alone, remains underdiagnosed and underfunded despite its significant impact on lives. This disease, which can severely affect education, careers, relationships, fertility, and overall quality of life, is still unknown to many. With...Read more
2024 23 Jul
Congenital cervical malformations (CCMs) are rare and complex deformities of the female lower genital tract. These anomalies arise due to the improper fusion of the Müllerian ducts or failure of subsequent canalisation during embryonic development. The prevalence of CCMs is relatively low, ranging from 1 to 1.25 cases per 100,000 individuals....Read more
2024 23 Jul
Congenital cervical malformations (CCMs) are rare and complex deformities of the female lower genital tract. These anomalies arise due to the improper fusion of the Müllerian ducts or failure of subsequent canalisation during embryonic development. The prevalence of CCMs is relatively low, ranging from 1 to 1.25 cases per 100,000 individuals....Read more
2024 28 May
Mammography is the main method for breast cancer screening but is less effective for individuals with dense breast tissue, who have a higher risk of cancer. Contrast-enhanced MRI is more sensitive but expensive and time-consuming. An abbreviated MRI (AB-MR) protocol shows promise in maintaining sensitivity while reducing time and cost. Studies...Read more
2024 28 May
Mammography is the main method for breast cancer screening but is less effective for individuals with dense breast tissue, who have a higher risk of cancer. Contrast-enhanced MRI is more sensitive but expensive and time-consuming. An abbreviated MRI (AB-MR) protocol shows promise in maintaining sensitivity while reducing time and cost. Studies...Read more
2024 20 May
Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, today announced it has signed an agreement to acquire 100% of the shares of Sonio SAS, a fetal ultrasound AI software company. Established in 2020 to enhance women and children’s health globally through medical advancements, Sonio has developed IT...Read more
2024 20 May
Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, today announced it has signed an agreement to acquire 100% of the shares of Sonio SAS, a fetal ultrasound AI software company. Established in 2020 to enhance women and children’s health globally through medical advancements, Sonio has developed IT...Read more
2024 20 May
Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, today announced it has signed an agreement to acquire 100% of the shares of Sonio SAS, a fetal ultrasound AI software company. Established in 2020 to enhance women and children’s health globally through medical advancements, Sonio has developed IT...Read more
2024 26 Apr
Leading Breast AI Company, creator of industry-leading Transpara®, promotes from within for new CEO ScreenPoint Medical announced a significant transition in its leadership as Mark Koeniguer, the current CEO, steps down from his position. Mark served as CEO since 2022 and was instrumental in ScreenPoint's commercial growth and success over...Read more